Laura Lynn Kovanda

17PUBLICATIONS
19CO-AUTHORS
PharmacogenomicsMedical infection agents (incl. prions)Psychosocial aspects of childbirth and perinatal mental healthChemotherapyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 22, 2026
Development of an isavuconazole physiologically-based pharmacokinetic model for adult and pediatric populations.

|Jul 22, 2026
Physiologically based pharmacokinetic (PBPK) model to predict the magnitude of drug-drug interaction between vincristine and the azole antifungals isavuconazole, posaconazole, and voriconazole in children.

|Nov 14, 2024
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.

Heidi Segers, Jaime G Deville, William J Muller

|May 15, 2023
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.

Kamal Hamed, Marc Engelhardt, Laura L Kovanda

|Mar 29, 2023
Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies.

Domenico Umberto De Rose, Iliana Bersani, Maria Paola Ronchetti

|Mar 30, 2021
Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.

Laura L Kovanda, Gabriele Sass, Marife Martinez

Pageof 3

Frequent Collaborators

5 joint publications

William W Hope

3 joint publications

Amit Desai

2 joint publications

Nathan Wiederhold

2 joint publications

Roger J Brüggemann